The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Immunodiagnostics-Global Market Insights and Sales Trends 2024
Synopsis
The global immunodiagnostics market is in the moderate growth stage. The integration of mature clinical chemistry analyzers and restricted specificity and sensitivity of immunoassays have generated demand for integrated immunochemistry analyzers. The increasing volume of tests conducted due to rise in laboratory consolidation has driven the trend of automated analyzers globally.
The global Immunodiagnostics market size is expected to reach US$ 17020 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Immunodiagnostics in various end use industries. The expanding demands from the Oncology and Endocrinology, Hepatitis and Retrovirus Testing, Infectious Disease Testing and GI Stool Testing, are propelling Immunodiagnostics market. Immunodiagnostic Instruments, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Immunoassays segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Immunodiagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Immunodiagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Immunodiagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Immunodiagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Immunodiagnostics covered in this report include Abbott Laboratories, Danaher, Roche Diagnostics, F.Hoffmann-La Roche, Thermo Fisher Scientific, Johnson＆Johnson and Siemens, etc.
The global Immunodiagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Danaher
Roche Diagnostics
F.Hoffmann-La Roche
Thermo Fisher Scientific
Johnson＆Johnson
Siemens
Global Immunodiagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immunodiagnostics market, Segment by Type:
Immunodiagnostic Instruments
Immunoassays
Global Immunodiagnostics market, by Application
Oncology and Endocrinology
Hepatitis and Retrovirus Testing
Infectious Disease Testing
GI Stool Testing
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Immunodiagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global immunodiagnostics market is in the moderate growth stage. The integration of mature clinical chemistry analyzers and restricted specificity and sensitivity of immunoassays have generated demand for integrated immunochemistry analyzers. The increasing volume of tests conducted due to rise in laboratory consolidation has driven the trend of automated analyzers globally.
The global Immunodiagnostics market size is expected to reach US$ 17020 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Immunodiagnostics in various end use industries. The expanding demands from the Oncology and Endocrinology, Hepatitis and Retrovirus Testing, Infectious Disease Testing and GI Stool Testing, are propelling Immunodiagnostics market. Immunodiagnostic Instruments, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Immunoassays segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Immunodiagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Immunodiagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Immunodiagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Immunodiagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Immunodiagnostics covered in this report include Abbott Laboratories, Danaher, Roche Diagnostics, F.Hoffmann-La Roche, Thermo Fisher Scientific, Johnson＆Johnson and Siemens, etc.
The global Immunodiagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Danaher
Roche Diagnostics
F.Hoffmann-La Roche
Thermo Fisher Scientific
Johnson＆Johnson
Siemens
Global Immunodiagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immunodiagnostics market, Segment by Type:
Immunodiagnostic Instruments
Immunoassays
Global Immunodiagnostics market, by Application
Oncology and Endocrinology
Hepatitis and Retrovirus Testing
Infectious Disease Testing
GI Stool Testing
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Immunodiagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Immunodiagnostics
1.1 Immunodiagnostics Market Overview
1.1.1 Immunodiagnostics Product Scope
1.1.2 Immunodiagnostics Market Status and Outlook
1.2 Global Immunodiagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Immunodiagnostics Market Size by Region (2018-2029)
1.4 Global Immunodiagnostics Historic Market Size by Region (2018-2023)
1.5 Global Immunodiagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Immunodiagnostics Market Size (2018-2029)
1.6.1 North America Immunodiagnostics Market Size (2018-2029)
1.6.2 Europe Immunodiagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Immunodiagnostics Market Size (2018-2029)
1.6.4 Latin America Immunodiagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Immunodiagnostics Market Size (2018-2029)
2 Immunodiagnostics Market by Type
2.1 Introduction
2.1.1 Immunodiagnostic Instruments
2.1.2 Immunoassays
2.2 Global Immunodiagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Immunodiagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Immunodiagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Immunodiagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Immunodiagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Immunodiagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Immunodiagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Immunodiagnostics Revenue Breakdown by Type (2018-2029)
3 Immunodiagnostics Market Overview by Application
3.1 Introduction
3.1.1 Oncology and Endocrinology
3.1.2 Hepatitis and Retrovirus Testing
3.1.3 Infectious Disease Testing
3.1.4 GI Stool Testing
3.2 Global Immunodiagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Immunodiagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Immunodiagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Immunodiagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Immunodiagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Immunodiagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Immunodiagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Immunodiagnostics Revenue Breakdown by Application (2018-2029)
4 Immunodiagnostics Competition Analysis by Players
4.1 Global Immunodiagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immunodiagnostics as of 2022)
4.3 Date of Key Players Enter into Immunodiagnostics Market
4.4 Global Top Players Immunodiagnostics Headquarters and Area Served
4.5 Key Players Immunodiagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Immunodiagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Immunodiagnostics Products, Services and Solutions
5.1.4 Abbott Laboratories Immunodiagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 Danaher
5.2.1 Danaher Profile
5.2.2 Danaher Main Business
5.2.3 Danaher Immunodiagnostics Products, Services and Solutions
5.2.4 Danaher Immunodiagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Danaher Recent Developments
5.3 Roche Diagnostics
5.3.1 Roche Diagnostics Profile
5.3.2 Roche Diagnostics Main Business
5.3.3 Roche Diagnostics Immunodiagnostics Products, Services and Solutions
5.3.4 Roche Diagnostics Immunodiagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 F.Hoffmann-La Roche Recent Developments
5.4 F.Hoffmann-La Roche
5.4.1 F.Hoffmann-La Roche Profile
5.4.2 F.Hoffmann-La Roche Main Business
5.4.3 F.Hoffmann-La Roche Immunodiagnostics Products, Services and Solutions
5.4.4 F.Hoffmann-La Roche Immunodiagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 F.Hoffmann-La Roche Recent Developments
5.5 Thermo Fisher Scientific
5.5.1 Thermo Fisher Scientific Profile
5.5.2 Thermo Fisher Scientific Main Business
5.5.3 Thermo Fisher Scientific Immunodiagnostics Products, Services and Solutions
5.5.4 Thermo Fisher Scientific Immunodiagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Thermo Fisher Scientific Recent Developments
5.6 Johnson＆Johnson
5.6.1 Johnson＆Johnson Profile
5.6.2 Johnson＆Johnson Main Business
5.6.3 Johnson＆Johnson Immunodiagnostics Products, Services and Solutions
5.6.4 Johnson＆Johnson Immunodiagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Johnson＆Johnson Recent Developments
5.7 Siemens
5.7.1 Siemens Profile
5.7.2 Siemens Main Business
5.7.3 Siemens Immunodiagnostics Products, Services and Solutions
5.7.4 Siemens Immunodiagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Siemens Recent Developments
6 North America
6.1 North America Immunodiagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Immunodiagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Immunodiagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Immunodiagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Immunodiagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Immunodiagnostics Market Dynamics
11.1 Immunodiagnostics Industry Trends
11.2 Immunodiagnostics Market Drivers
11.3 Immunodiagnostics Market Challenges
11.4 Immunodiagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
